These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 26169974)

  • 41. C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia.
    Fawzi MH; Fawzi MM; Fawzi MM; Said NS
    Psychiatry Res; 2011 Nov; 190(1):91-7. PubMed ID: 21621854
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Possible effects of some antipsychotic drugs on C-reactive protein in a drug-naïve psychotic sample.
    Diaz FJ; Pérez-Iglesias R; Mata I; Martínez-Garcia O; Vázquez-Barquero JL; de Leon J; Crespo-Facorro B
    Schizophr Res; 2010 Aug; 121(1-3):207-12. PubMed ID: 20580206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation.
    Pedrini M; Chendo I; Grande I; Lobato MI; Belmonte-de-Abreu PS; Lersch C; Walz J; Kauer-Sant'anna M; Kapczinski F; Gama CS
    Neurosci Lett; 2011 Mar; 491(3):207-10. PubMed ID: 21256922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abnormal Trajectory of Intracortical Myelination in Schizophrenia Implicates White Matter in Disease Pathophysiology and the Therapeutic Mechanism of Action of Antipsychotics.
    Tishler TA; Bartzokis G; Lu PH; Raven EP; Khanoyan M; Kirkpatrick CJ; Pyle MH; Villablanca JP; Altshuler LL; Mintz J; Ventura J; Casaus LR; Subotnik KL; Nuechterlein KH; Ellingson BM
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 May; 3(5):454-462. PubMed ID: 29735155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estimated dopamine D2 receptor occupancy from plasma concentrations of atypical antipsychotics and subjective experience/drug attitude in schizophrenia: an analysis of the CATIE data.
    Takeuchi H; Suzuki T; Bies RR; Remington G; Mamo DC; Pollock BG; Mimura M; Uchida H
    Schizophr Res; 2013 Nov; 150(2-3):373-9. PubMed ID: 24028745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein.
    Dieset I; Hope S; Ueland T; Bjella T; Agartz I; Melle I; Aukrust P; Røssberg JI; Andreassen OA
    Schizophr Res; 2012 Sep; 140(1-3):169-74. PubMed ID: 22817875
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neutrophil-to-lymphocyte ratio in schizophrenia: A systematic review and meta-analysis.
    Karageorgiou V; Milas GP; Michopoulos I
    Schizophr Res; 2019 Apr; 206():4-12. PubMed ID: 30573407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clozapine therapy raises serum concentrations of high sensitive C-reactive protein in schizophrenic patients.
    Löffler S; Löffler-Ensgraber M; Fehsel K; Klimke A
    Int Clin Psychopharmacol; 2010 Mar; 25(2):101-6. PubMed ID: 20101184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Common and disorder-specific upregulation of the inflammatory markers TRAIL and CCL20 in depression and schizophrenia.
    Klaus F; Guetter K; Schlegel R; Spiller TR; Seifritz E; Cathomas F; Kaiser S
    Sci Rep; 2021 Sep; 11(1):19204. PubMed ID: 34584171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment.
    de Witte L; Tomasik J; Schwarz E; Guest PC; Rahmoune H; Kahn RS; Bahn S
    Schizophr Res; 2014 Apr; 154(1-3):23-9. PubMed ID: 24582037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between C-reactive protein levels and antipsychotic treatment during 12 months follow-up period after acute psychosis.
    Fathian F; Gjestad R; Kroken RA; Løberg EM; Reitan SK; Fleichhacker WW; Rettenbacher M; Larsen TK; Joa I; Stabell LA; Kjelby E; Sinkevicute I; Alisauskiene R; Steen VM; Johnsen E
    Schizophr Res; 2022 Mar; 241():174-183. PubMed ID: 35131596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between degree centrality and neurocognitive impairments in patients with Schizophrenia: A Longitudinal rs-fMRI Study.
    Feng S; Huang Y; Lu H; Li H; Zhou S; Lu H; Feng Y; Ning Y; Han W; Chang Q; Zhang Z; Liu C; Li J; Wu K; Wu F
    J Psychiatr Res; 2024 May; 173():115-123. PubMed ID: 38520845
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Self-reported pain in patients with schizophrenia. Results from the national first-step FACE-SZ cohort.
    Fond G; Boyer L; Andrianarisoa M; Godin O; Bulzacka E; Berna F; Brunel L; Coulon N; Aouizerate B; Capdevielle D; Chereau I; D'amato T; Denizot H; Dubertret C; Dubreucq J; Faget C; Leignier S; Mallet J; Misdrahi D; Rey R; Lancon C; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Schurhoff F; Llorca PM;
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():62-68. PubMed ID: 29678770
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atypical antipsychotics cause an acute increase in cutaneous hand blood flow in patients with schizophrenia and schizoaffective disorder.
    Blessing E; Kader L; Arpandy R; Ootsuka Y; Blessing WW; Pantelis C
    Aust N Z J Psychiatry; 2011 Aug; 45(8):646-53. PubMed ID: 21870922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Depressive symptoms and chronic peripheral inflammation are associated with impaired functional remission in schizophrenia independently of psychotic remission.
    Fond G; Faugere M; Richieri R; Cermolacce M; Korchia T; Micoulaud-Franchi JA; Sunhary de Verville PL; Boyer L; Lançon C
    J Affect Disord; 2021 Feb; 280(Pt A):267-271. PubMed ID: 33220563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C-reactive protein is elevated in schizophrenia.
    Dickerson F; Stallings C; Origoni A; Vaughan C; Khushalani S; Yang S; Yolken R
    Schizophr Res; 2013 Jan; 143(1):198-202. PubMed ID: 23218564
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of sICAM-1 and sVCAM-1 as biomarkers in early and late stages of schizophrenia.
    Stefanović MP; Petronijević N; Dunjić-Kostić B; Velimirović M; Nikolić T; Jurišić V; Lačković M; Damjanović A; Totić-Poznanović S; Jovanović AA; Ivković M
    J Psychiatr Res; 2016 Feb; 73():45-52. PubMed ID: 26679764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.